Clinical Trial Update: A Phase IIIb Study of BMS-188667 in Subjects With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate [Phase 3]

View source ↗

Summary

Phase IIIb trial evaluating BMS-188667 in patients with active rheumatoid arthritis who had an inadequate response to methotrexate. The study has completed and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• BMS-188667
• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Active Rheumatoid Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2011-05-17